Skip to main content
. Author manuscript; available in PMC: 2010 Sep 8.
Published in final edited form as: Circulation. 2009 Aug 24;120(10):876–887. doi: 10.1161/CIRCULATIONAHA.109.852285

Figure 3.

Figure 3

Ventricular function. Combination therapy (CPC-NF-IGF-1) attenuated the most the negative impact of myocardial infarction on cardiac performance. See Figure 2 for symbols.